Form 4: ResMed Director Sells Shares, Tax Withholding Reported
Insider Transaction Report
ResMed Inc. Director Peter C. Farrell reported the sale of 2,000 common shares and a tax-related disposition of 162.953 shares.
Summary
- Peter C. Farrell, a Director of ResMed Inc. (RMD), reported two transactions involving the company's common stock.
- On November 11, 2025, 162.953 shares were disposed of to the issuer for tax withholding purposes related to the vesting of Restricted Stock Units (RSUs) granted on November 20, 2024. The price per share for this disposition was $250.1.
- Following this tax-related disposition, Mr. Farrell beneficially owned 68,110 shares directly.
- On November 12, 2025, Mr. Farrell sold 2,000 shares of ResMed Common Stock at a price of $252.05 per share.
- This sale was conducted under a Rule 10b5-1 plan, which was adopted on August 12, 2025.
- After both reported transactions, Mr. Farrell's direct beneficial ownership stands at 66,110 shares.
Sentiment
Score: 5
Explanation: This is a routine insider transaction filing, detailing a planned sale and a tax-related disposition, which are common occurrences for executives and directors. It does not inherently suggest a significant positive or negative shift in company fundamentals.
Negatives
- The filing indicates insider selling, which, while planned, can sometimes be perceived as a minor negative signal by some investors.
Stakeholder Impact
- Shareholders will note the reduction in direct beneficial ownership by a director, although the transactions are relatively small and include a planned sale and tax-related disposition.
Key Dates
| Date | Description |
|---|---|
| 11/20/2024 | Date of grant for Restricted Stock Units (RSUs) that vested. |
| 08/12/2025 | Date the Rule 10b5-1 plan was adopted by Peter C. Farrell. |
| 11/11/2025 | Date of disposition of 162.953 shares for tax withholding on RSU vesting. |
| 11/12/2025 | Date of sale of 2,000 shares of common stock under a Rule 10b5-1 plan. |
| 11/13/2025 | Date the Form 4 was signed by the attorney-in-fact for Mr. Farrell. |
Recommendation
holdThe filing details routine insider transactions, including a planned sale under Rule 10b5-1 and a tax-related disposition. These transactions are common and do not typically indicate a significant change in company fundamentals or future prospects, thus a 'hold' recommendation is appropriate based solely on this filing.
Keywords
ResMed, RMD, Insider Trading, Form 4, Stock Sale, Director, Peter C. Farrell, 10b5-1 Plan, Tax Withholding, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.